Atrás
Rango del Día
$14.39
$14.42
Rango de 52 Semanas
$5.51
$14.43
Volumen
2,579,252
Promedio 50D / 200D
$14.33
/
$9.82
Cierre Anterior
$14.43
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -167.0 | 0.4 |
| P/B | 16.5 | 2.9 |
| ROE % | -11.6 | 3.8 |
| Net Margin % | -4.3 | 3.9 |
| Rev Growth 5Y % | 20.0 | 10.0 |
| D/E | 1.8 | 0.2 |
Precio Objetivo de Analistas
Hold
$14.50
+0.6%
P/E Futuro
47.6
EPS Futuro
$0.30
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
750 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$1.67
$1.62 – $1.72
|
1.5 B | 2 |
| FY2029 |
$1.36
$1.32 – $1.40
|
1.3 B | 2 |
| FY2028 |
$0.91
$0.75 – $1.05
|
1.1 B | 4 |
Puntos Clave
Revenue grew 20.03% annually over 5 years — strong growth
Generating 29.85M in free cash flow
Capital efficient — spends only 0.52% of revenue on capex
ROIC of 3.41% — low return on invested capital
Interest coverage of 0.75× — tight debt servicing
Crecimiento
Revenue Growth (5Y)
20.03%
Revenue (1Y)20.05%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-11.58%
ROIC3.41%
Net Margin-4.27%
Op. Margin5.44%
Seguridad
Debt / Equity
1.76
Current Ratio2.84
Interest Coverage0.75
Valoración
P/E Ratio
-167.02
P/B Ratio16.51
EV/EBITDA139.09
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 20.05% | Revenue Growth (3Y) | 26.02% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 20.03% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 634.21M | Net Income (TTM) | -27.11M |
| ROE | -11.58% | ROA | -2.85% |
| Gross Margin | 87.32% | Operating Margin | 5.44% |
| Net Margin | -4.27% | Free Cash Flow (TTM) | 29.85M |
| ROIC | 3.41% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.76 | Current Ratio | 2.84 |
| Interest Coverage | 0.75 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -167.02 | P/B Ratio | 16.51 |
| P/S Ratio | 7.14 | PEG Ratio | 3.17 |
| EV/EBITDA | 139.09 | Dividend Yield | 0.00% |
| Market Cap | 4.53B | Enterprise Value | 4.80B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 634.21M | 528.30M | 399.36M | 329.23M | 305.51M |
| Net Income | -27.11M | -56.11M | -151.58M | -236.57M | -250.46M |
| EPS (Diluted) | -0.09 | -0.18 | -0.51 | -0.82 | -0.92 |
| Gross Profit | 553.82M | 475.35M | 362.03M | 290.63M | 271.05M |
| Operating Income | 34.49M | 24.88M | -77.21M | -212.12M | -206.43M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 949.87M | 785.03M | 777.88M | 724.17M | 905.14M |
| Total Liabilities | 675.63M | 590.99M | 617.71M | 601.12M | 597.77M |
| Shareholders' Equity | 274.24M | 194.05M | 160.17M | 123.05M | 307.37M |
| Total Debt | 483.33M | 443.64M | 445.06M | 452.12M | 440.13M |
| Cash & Equivalents | 214.01M | 213.75M | 246.99M | 148.81M | 245.20M |
| Current Assets | 676.17M | 504.74M | 483.06M | 423.82M | 596.83M |
| Current Liabilities | 237.83M | 148.70M | 167.69M | 139.02M | 145.98M |